{"id":"W2776526327","doi":"10.1371/journal.pone.0189848","title":"Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma","year":2017,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":305,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Rutgers Cancer Institute of New Jersey; Merck; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Internal medicine; Gastroenterology; Adverse effect; Rectum; Colorectal cancer; Microsatellite instability; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00113416,0.000245798,0.0007670812,0.0002310647,0.0002216992,0.0003319087,0.0001562904,0.0002846474,0.0005543674],"category_scores_gemma":[0.001525378,0.000130657,0.0003765952,0.0002624484,0.0002125048,0.0002492461,0.0001401249,0.0007684654,0.000180033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005441819,"about_ca_system_score_gemma":0.0004068495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004717626,"about_ca_topic_score_gemma":0.0007571291,"domain_scores_codex":[0.9997057,0.000128209,0.0000267661,0.00004504934,0.00006187856,0.0000323228],"domain_scores_gemma":[0.9992033,0.0002440012,0.0002649899,0.0000441127,0.00007305677,0.0001705797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2058567,0.005641002,0.40844,0.000837014,0.001556139,0.0009390061,0.0005985844,0.003698091,0.04588352,0.0001583292,0.002956363,0.3234353],"study_design_scores_gemma":[0.03233756,0.1781143,0.7625989,0.0001533021,0.001292165,0.002494904,0.0001775122,0.004812183,0.009719885,0.0002729453,0.00798786,0.00003832116],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969622,0.002148974,0.0001233985,0.0001219344,0.000009863676,0.00004421584,0.0001221767,0.00001026952,0.0004569523],"genre_scores_gemma":[0.9989889,0.0004688808,0.0001094254,0.00009271369,0.00002705863,0.00002841616,0.0001817394,0.00000183868,0.0001010412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00113416,"threshold_uncertainty_score":0.005998075,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01388571763234961,"score_gpt":0.2425488519917105,"score_spread":0.2286631343593609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}